Kev Somers

A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.

Sally Robinson, Kathryn Chapman, David Dreher, 2008, Regulatory toxicology and pharmacology : RTP.

Challenging the regulatory requirement for conventional acute toxicity studies in pharmaceutical drug development

David Dreher, Kathryn L Chapman, S. Robinson, 2007 .

A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studies.

Fiona Sewell, Sally Robinson, Kathryn Chapman, 2013, Regulatory toxicology and pharmacology : RTP.

A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.

David Dreher, Kathryn L Chapman, M. Festag, 2008, Regulatory toxicology and pharmacology : RTP.